{"id":15972,"date":"2025-10-16T15:33:45","date_gmt":"2025-10-16T12:33:45","guid":{"rendered":"https:\/\/www.edarges.ro\/www\/?p=15972"},"modified":"2025-10-31T15:42:36","modified_gmt":"2025-10-31T13:42:36","slug":"comisia-autorizeaza-un-medicament-pentru-tratarea-stadiilor-incipiente-de-alzheimer","status":"publish","type":"post","link":"https:\/\/www.edarges.ro\/www\/?p=15972","title":{"rendered":"Comisia autorizeaz\u0103 un medicament pentru tratarea stadiilor incipiente de Alzheimer"},"content":{"rendered":"<p style=\"text-align: justify;\">Comisia European\u0103 a acordat autoriza\u021bia UE de comercializare pentru Kisunla, un medicament pentru tratarea tulbur\u0103rii cognitive u\u0219oare, inclusiv a demen\u021bei u\u0219oare \u00een stadiile incipiente ale bolii Alzheimer.<\/p>\n<p style=\"text-align: justify;\">Kisunla poate contribui la \u00eencetinirea evolu\u021biei problemelor cognitive \u0219i func\u021bionale asociate cu boala Alzheimer la anumi\u021bi pacien\u021bi. Autoriza\u021bia se bazeaz\u0103 pe evaluarea \u0219tiin\u021bific\u0103 pozitiv\u0103 efectuat\u0103 de Agen\u021bia European\u0103 pentru Medicamente,\u00a0care a concluzionat c\u0103 beneficiile acestui medicament sunt mai mari dec\u00e2t riscurile pentru o anumit\u0103 popula\u021bie de pacien\u021bi cu Alzheimer \u00een stadiu incipient.<\/p>\n<p style=\"text-align: justify;\">Decizia de autorizare stabile\u0219te condi\u021bii stricte privind utilizarea Kisunla, deoarece este considerat adecvat numai pentru pacien\u021bii cu o anumit\u0103 dispozi\u021bie genetic\u0103. De asemenea, sunt prezentate m\u0103suri clare de reducere a riscurilor, precum cerin\u021be de monitorizare \u0219i de etichetare.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Comisia European\u0103 a acordat autoriza\u021bia UE de comercializare pentru Kisunla, un medicament pentru tratarea tulbur\u0103rii cognitive u\u0219oare, inclusiv a demen\u021bei u\u0219oare \u00een stadiile incipiente ale bolii Alzheimer. Kisunla poate contribui la \u00eencetinirea evolu\u021biei problemelor cognitive \u0219i func\u021bionale asociate cu boala Alzheimer la anumi\u021bi pacien\u021bi. Autoriza\u021bia se bazeaz\u0103 pe evaluarea \u0219tiin\u021bific\u0103 pozitiv\u0103 efectuat\u0103 de Agen\u021bia European\u0103 &hellip; <a href=\"https:\/\/www.edarges.ro\/www\/?p=15972\">Continued<\/a><\/p>\n","protected":false},"author":4,"featured_media":11140,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[17],"tags":[],"_links":{"self":[{"href":"https:\/\/www.edarges.ro\/www\/index.php?rest_route=\/wp\/v2\/posts\/15972"}],"collection":[{"href":"https:\/\/www.edarges.ro\/www\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.edarges.ro\/www\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.edarges.ro\/www\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.edarges.ro\/www\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=15972"}],"version-history":[{"count":1,"href":"https:\/\/www.edarges.ro\/www\/index.php?rest_route=\/wp\/v2\/posts\/15972\/revisions"}],"predecessor-version":[{"id":15973,"href":"https:\/\/www.edarges.ro\/www\/index.php?rest_route=\/wp\/v2\/posts\/15972\/revisions\/15973"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.edarges.ro\/www\/index.php?rest_route=\/wp\/v2\/media\/11140"}],"wp:attachment":[{"href":"https:\/\/www.edarges.ro\/www\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=15972"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.edarges.ro\/www\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=15972"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.edarges.ro\/www\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=15972"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}